Femora and tibiae of rats carrying leukemia from a L a dmarked acute promyelocytic leukemia-derived leukemic cell line (LT12NL15) were decalcified using EDTA and routinely embedded in paraffin. Sections were used to develop for the first time an immunostaining method for Lad, employing catalyzed reporter deposition (CARD) based on the deposi-tion of biotinylated tyramine. This method was used to study homing and adhesion of leukemic cells. ( J Hisrochem   Cyrochem 44:1323-1329, 19%) 
Introduction
In acute myelocytic leukemia (AML). infiltration of the bone marrow with leukemic cells is accompanied by severe suppression of normal hematopoiesis, eventually leading to life-threatening bleeding problems, recurrent infections, and anemia. To investigate whether this suppression of normal hematopoiesis is caused by spatial competition between normal hematopoietic stem cells and leukemic cells, Prim and Van Bekkum (1981) injected tritiated thymidine-labeled leukemic cells from the in vivo growing Brown Norway acute myelocytic leukemia (BNML) cell line, a wellcharacterized model of human AML (reviewed by Martens et al., 1990) . into rats. It was subsequently observed that these cells were preferentially localized in the subendosteal region of the femoral bone marrow, in contrast to L4415 cells, a rat model for human acute lymphocytic leukemia (Kloosterman et al., 1992; Prins and Van Bekkum, 1981) . This led to the assumption that AML cells specifically compete for space in the bone marrow compartment that is normally occupied by immature hemopoietic progenitor cells (Van Bekkum et al., 1981) . To extend the study of the growth pattern and localization of acute myelocytic leukemia cells and to elucidate the role of adhesion molecules in this process, a more versatile and permanent method to mark leukemic cells was required.
Genetic marking using the ErGherzchia coli B-galactosidase gene (LacZ) is a widely used method for the identification and localization of transplanted cells in vivo (Cui et al., 1994) an in vitro growing derivative of the BNML cell line (Lacaze et al., 1983) . This resulted in the development of a genetically marked leukemic cell line, LT12NL15, which exhibits stable expression of large amounts of E. cofi P-galactosidase in the cytoplasm of every cell (Hendrikx et al., 1995; Yan et al., 1993) . These cells were used to set up a sensitive system to study homing and growth of leukemic cells (Hendrikx et al., 1995) . Here we report the development of an immunohistochemical staining method for Lac2 in paraffin sections of formalin-fixed, decalcified tibiae and femora of rats carrying LT12NL15 leukemia. This method allows detailed visualization of genetically marked leukemic cells within the undisturbed spatial context of the bone marrow and the enclosing bone. This procedure may also be of value to other studies in which detection of Lac2 labeled cells in p d i sections can o&r increased specificity, greater convenience, and superior tissue preservation compared to frozen sections.
Materials and Methods
Cells. LT12 is an in vitro as well as in vivo growing rat acute promyelocytic leukemia cell line, derived from the in vivo growing BNML cell line (Hagenbeek, 1977) . LT12 cells were genetically marked using a retroviral vector containing the L a d gene, resulting in the subline LT12NL15. Briefly, LTl2 cells were co-cultured with the BAG retrovirus (Price et al., 1987) in the presence of polybrene. After 36 hr of co-culture the cells were placed under G418 selection pressure in an agar culture system. Ten days later resistant colonies were picked and expanded. After extensive in vitro and in vivo passaging of the resulting series of sublines, the LT12NL15 subline was selected for use in further experiments (Yan et al., 1993) . LTlZNLlS cells were cultured in Alpha Modification of Eagle's Medium (a-MEM) supplemented with 10% fetal calf serum (Gibcq Breda, The Netherlands).
Animals. SPF quality Brown Norway (BN) rats from the BNlRijHsd strain were purchased from Harlan CPB (Zeist, The Netherlands). Leukemia was induced by injecting LT12NL15 cells via the lateral tail vein of etheranesthetized rats.
Immunological Reagents. The primary antiserum was a rabbit antiserum to E. coli p-galactosidase (5-Prime 3-Prime; Boulder, CO). The secondary antibody was HRP-conjugated donkey anti-rabbit, absorbed for rat, human, and mouse (DAR-HRP; Amersham, Arlington Heights, IL). Biotinylated tyramine and streptavidin-HRP conjugate were as supplied in the Tyramide Signal Amplification kit (DuPont/New England Nuclear; Boston, MA).
Staining. Rats were ether-anesthetized and bled through the aorta. Subsequently, femora and tibiae were removed, cleaned of muscle tissue, and fixed in 4% buffered paraformaldehyde for 1-5 weeks. Decalcification was performed for 3 weeks at room temperature (RT) under continuous stirring in 10% EDTA in distilled water, using sodium hydroxide to raise the pH to 8.0 to increase solubility of the EDTA. After decalcification the bones were dehydrated and embedded in paraffin according to standard procedures. Sections were prepared on SuperFrost microscope slides (Menzel: Braunschweig, Germany) coated with 3-aminopropyl-triethoxysilan (Sigma Chemicals; Bornem, Belgium) to improve adhesion of the sections to the glass surface. Before staining, the sections were deparaffinized and rehydrated to distilled water using a standard graded xylene-ethanol series. Extensive testing of multiple staining parameters led to the following reliable staining protocol. 
Results
Extensive testing resulted in a reliable method to stain LacZ-marked cells in paraffin sections of decalcified bones. Table 1 demonstrates that a 45-min trypsinization step gave optimal staining results while preserving the bone matrix integrity in the sections. an overview of the staining modalities that were tested before arriving at the protocol described above. Figure 1A shows a photomicrograph of a tibia of a rat 12 days after injection of lo6 LTl2NLl5 cells. Quantitative analysis of the bone marrow using the sticky plate assay (Hendrikx et al., 1995) showed that the frequency of leukemic cells in the bone m " w of this rat was approximately 1 per lo2 normal marrow cells (data not shown). The LacZ-expressing leukemic cells can easily be recognized by their DAB staining. This figure shows a representative example of the typically observed growth pattern of IT12NL15 cells, which is characterized by focal growth in a loose formation, seemingly unconnected to any structural element of the bone marrow. Figure 1B shows an adjacent control section that was stained without the primary antibody. Note the absence of any DAB reaction product. Other controls were sections of control rats stained with and without primary antibody. No DAB reaction product was seen in these sections (not shown). Figure 1C shows a higher-magnification image of LacZ-stained LT12NL15 cells. The DAB reaction product is localized in the cytoplasm of the leukemic cells.
Discussion
The LacZ gene that encodes for 0-galactosidase in E. coliis widely used as a genetic marker of cells, as a reporter gene in genetic modification experiments, and as a reporter sequence in the production of fusion proteins. This frequent application is owed to the wide range of assays available to detect its activity (Hagenbeek, 1992) and the robustness of the enzyme (Fire, 1992) .
In mammalian tissues, problems are sometimes encountered with background activity from various endogenous 0-galactosidases (Hatton and Lin, 1992) . This problem can to a great extent be alleviated by the application of D-@actose in staining solutions, which acts as a differential suppressor of background activity (Hendrikx er al., 1994) . or by using immunohistochemical procedures (Shimohama et al., 1989) .
Because of the robustness of the enzyme, X-gal staining of frozen sections has been the method of choice for most localization studies. For analysis of X-gal localization in bone marrow this is, however, not a very attractive option, because only specialized and time-consuming methods for the preparation of frozen sections from undecalcified bone have been described (McElroy et al., 1993; Aaron and Carter, 1987) . Another option is the cold glycol methacrylate embedding method as described by Lin et al. (1992) , but this requires the use of heavy-duty microtomes for sectioning hard tissues, which are not readily available in every laboratory. We therefore decided to develop a protocol for staining routine paraffinembedded sections of decalcified bones. Enzyme histochemistry is then no longer an option, since the enzyme becomes inactivated in the process of decalcification and em bedding. Several monoclonal and polyclonal antibodies to E. coli 0-galactosidase were tested in conjunction with a range of epitope-unmasking techniques. Using the 5 Prime-3 Prime polyclonal rabbit antiserum (Hanvey et al., 1992; Shimohama et al., 1989) . we showed that trypsinization could render the paraffin sections stainable with a simple procedure, although with variable result. Incorporation into the protocol of a biotinylated tyramide-intensification step (CARD) (Kentens et al., 1995; Adams, 1992; Bobrow et al., 1989) led to a reliable and re-producible staining procedure. As demonstrated in Figure 1 , this method shows unequivocally the focal growth of IT12NL15 leukemic cells in the bone marrow.
Although this method allows L a d staining of bone marrow paraffin sections, its good tissue preservation, ease of use, and the absence of background 0-galactosidase staining provides the perspective of a much wider applicability. Furthermore, this method will bring the use of LacZ marking within the scope of clinical studies in which bone marrow autografts are genetically marked to study the kinetic and spatial behavior of transplanted LacZ-marked hemopoietic stem cells and of co-transplanted residual tumor cells (Deisseroth et al., 1994; Rill er al., 1992) . 
